PL3411389T3 - Nowe proteazy streptokokowe - Google Patents

Nowe proteazy streptokokowe

Info

Publication number
PL3411389T3
PL3411389T3 PL17703958T PL17703958T PL3411389T3 PL 3411389 T3 PL3411389 T3 PL 3411389T3 PL 17703958 T PL17703958 T PL 17703958T PL 17703958 T PL17703958 T PL 17703958T PL 3411389 T3 PL3411389 T3 PL 3411389T3
Authority
PL
Poland
Prior art keywords
proteases
new
new streptococcal
streptococcal proteases
streptococcal
Prior art date
Application number
PL17703958T
Other languages
English (en)
Inventor
Ulrich Von Pawel-Rammingen
Christian SPOERRY
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57995190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3411389(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of PL3411389T3 publication Critical patent/PL3411389T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641Cysteine endopeptidases (3.4.22)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PL17703958T 2016-02-04 2017-02-03 Nowe proteazy streptokokowe PL3411389T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1630021 2016-02-04
EP17703958.3A EP3411389B1 (en) 2016-02-04 2017-02-03 New streptococcal proteases
PCT/EP2017/052463 WO2017134274A1 (en) 2016-02-04 2017-02-03 New streptococcal proteases

Publications (1)

Publication Number Publication Date
PL3411389T3 true PL3411389T3 (pl) 2021-10-25

Family

ID=57995190

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17703958T PL3411389T3 (pl) 2016-02-04 2017-02-03 Nowe proteazy streptokokowe

Country Status (13)

Country Link
US (1) US12006530B2 (pl)
EP (1) EP3411389B1 (pl)
JP (2) JP7123801B2 (pl)
KR (1) KR102704583B1 (pl)
CN (1) CN109311951B (pl)
AU (1) AU2017214441B2 (pl)
CA (1) CA3013527C (pl)
DK (1) DK3411389T3 (pl)
ES (1) ES2877754T3 (pl)
PL (1) PL3411389T3 (pl)
PT (1) PT3411389T (pl)
SG (1) SG11201806639VA (pl)
WO (1) WO2017134274A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3387898T (pt) 2013-03-15 2020-06-17 Mayo Found Medical Education & Res Identificação e monitorização de imunoglobulinas monoclonais pela massa molecular
EP3126826B1 (en) 2014-04-04 2020-12-16 Mayo Foundation for Medical Education and Research Isotyping immunoglobulins using accurate molecular mass
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
PL3411389T3 (pl) 2016-02-04 2021-10-25 Genovis Ab Nowe proteazy streptokokowe
AU2017325022B2 (en) 2016-09-07 2022-10-13 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
KR102608876B1 (ko) 2017-05-26 2023-11-30 게노비스 에이비 글리칸 분석을 위한 효소
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
JP7425728B2 (ja) * 2017-12-15 2024-01-31 インターベット インターナショナル ベー. フェー. レンサ球菌感染防御のためのワクチン
WO2021067598A1 (en) 2019-10-04 2021-04-08 Ultragenyx Pharmaceutical Inc. Methods for improved therapeutic use of recombinant aav
EP4103724A1 (en) 2020-02-14 2022-12-21 Ultragenyx Pharmaceutical Inc. Gene therapy for treating cdkl5 deficiency disorder
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
US20230364207A1 (en) * 2020-06-18 2023-11-16 Shanghai Bao Pharmaceuticals Co., Ltd. Mutant of immunoglobulin degrading enzyme idee
JP2023545731A (ja) 2020-10-07 2023-10-31 アスクレピオス バイオファーマシューティカル, インコーポレイテッド 肢帯型2i(lgmd2i)を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質(fkrp)の治療的アデノ随伴ウイルス送達
EP4323015A4 (en) 2021-04-16 2025-10-22 Askbio Inc RATIONALLY POLYPLOID AAV VIRIONS CROSS THE BLOOD-BRAIN BARRIER AND TRIGGER A REDUCED HUMORAL RESPONSE
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
WO2022266044A1 (en) * 2021-06-15 2022-12-22 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
JP2024531138A (ja) 2021-08-11 2024-08-29 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 筋ジストロフィーを処置するための組成物および方法
CN118265540A (zh) * 2021-11-18 2024-06-28 英特维特国际股份有限公司 产生针对猪链球菌的疫苗的方法以及所述疫苗
CN120265651A (zh) * 2022-11-25 2025-07-04 中外制药株式会社 用于生产蛋白质的方法
WO2025047641A1 (ja) 2023-08-25 2025-03-06 積水メディカル株式会社 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、及び免疫学的測定用試薬キット、非特異反応抑制剤
WO2025256978A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Variants of igm and igg cleaving enzymes
WO2025256977A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Novel igm and igg cleaving enzymes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
AU2005319174A1 (en) 2004-12-22 2006-06-29 J. Craig Venter Institute, Inc. Group B Streptococcus
ES2380950T3 (es) 2005-06-09 2012-05-21 Hansa Medical Ab Uso de la proteinasa IdeS ( de S, pyogenes) para tratar enfermedades autoinmunitarias y rechazo de injerto
WO2009033670A2 (en) 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
PL3411389T3 (pl) 2016-02-04 2021-10-25 Genovis Ab Nowe proteazy streptokokowe

Also Published As

Publication number Publication date
CN109311951A (zh) 2019-02-05
PT3411389T (pt) 2021-06-28
ES2877754T3 (es) 2021-11-17
JP7123801B2 (ja) 2022-08-23
EP3411389A1 (en) 2018-12-12
KR20180124857A (ko) 2018-11-21
US12006530B2 (en) 2024-06-11
JP2019506866A (ja) 2019-03-14
DK3411389T3 (da) 2021-06-21
WO2017134274A1 (en) 2017-08-10
EP3411389B1 (en) 2021-03-24
SG11201806639VA (en) 2018-09-27
AU2017214441B2 (en) 2021-08-19
AU2017214441A1 (en) 2018-08-16
CA3013527C (en) 2023-09-05
JP2022115853A (ja) 2022-08-09
CN109311951B (zh) 2022-10-11
KR102704583B1 (ko) 2024-09-06
CA3013527A1 (en) 2017-08-10
US20190345533A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
PT3411389T (pt) Novas proteases estreptocócicas
IL253939B (en) cysteine protease
IL253938A0 (en) cysteine protease
GB2550864B (en) Well
AU201616677S (en) Cylindres
GB201621111D0 (en) Neurotoxins
GB201614455D0 (en) Biomarkers
SG10202007262PA (en) Copanlisib biomarkers
SG10202007322PA (en) Copanlisib biomarkers
PL3458583T3 (pl) Proteazy o polepszonej skuteczności
AU201617244S (en) Case
GB201513444D0 (en) Peptoid
PL3469691T3 (pl) Konfiguracja szyku halbacha
PT3420078T (pt) Variantes da beta-lactamase
GB201715589D0 (en) Protease inhibitors
PH32016000939S1 (en) L-shaped construction block
GB201618005D0 (en) Keys
GB201615101D0 (en) Keys
GB201611096D0 (en) Face up
GB201621467D0 (en) Modified bulgeomers
PH32016000328S1 (en) Mascot
GB201616374D0 (en) Modified bulgeomers
GB201614858D0 (en) Modified Bulgeomers
GB201600509D0 (en) Keys
GB201611746D0 (en) Snagg free